Literature DB >> 7696968

Signal transduction through homo- or heterodimers of gp130.

T Kishimoto1.   

Abstract

One of the characteristic features of cytokines is their functional pleiotropy and redundancy which can now be explained on the molecular basis of the cytokine receptor system. The cytokine receptor system usually consists of two polypeptide chains, a ligand specific receptor and a common signal transducer. The IL-6 receptor system consists of an 80 kDa IL-6 receptor and a gp130 which functions as a signal transducer not only for IL-6R but also for LIF, OSM, ciliary neurotrophic factor (CNTF), and IL-11 receptors. Interaction of IL-6 and IL-6 receptor induces homodimerization of gp130 which interacts and activates an intracytoplasmic tyrosine kinase, JAK-1 kinase. A downstream substrate of JAK kinase in hepatocytes is acute phases responsive factor (APRF)/STAT3. After tyrosine specific phosphorylation of APRF, it translocates into nuclei, binds to type 2 IL-6 responsive element and induces acute phase gene expression. In order to study in vivo roles of the signaling molecules, targeted disruptions of the genes encoding gp130 and NF IL-6 were carried out. The result revealed the essential role of gp130 in hemopoiesis and heart muscle development. NF IL-6 was shown to be essential for bactericidal function of macrophages.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7696968

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  6 in total

1.  Zap70 functions to maintain stemness of mouse embryonic stem cells by negatively regulating Jak1/Stat3/c-Myc signaling.

Authors:  Young Cha; Bo-hyun Moon; Mi-ok Lee; Hee-jin Ahn; Hye-jin Lee; Kyung-ah Lee; Albert J Fornace; Kwang-soo Kim; Hyuk-jin Cha; Kyung-soon Park
Journal:  Stem Cells       Date:  2010-09       Impact factor: 6.277

2.  Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis.

Authors:  Carole Henique; Guillaume Bollée; Xavier Loyer; Florian Grahammer; Neeraj Dhaun; Marine Camus; Julien Vernerey; Léa Guyonnet; François Gaillard; Hélène Lazareth; Charlotte Meyer; Imane Bensaada; Luc Legrès; Takashi Satoh; Shizuo Akira; Patrick Bruneval; Stefanie Dimmeler; Alain Tedgui; Alexandre Karras; Eric Thervet; Dominique Nochy; Tobias B Huber; Laurent Mesnard; Olivia Lenoir; Pierre-Louis Tharaux
Journal:  Nat Commun       Date:  2017-11-28       Impact factor: 14.919

3.  Ectopic CD137 expression by rhabdomyosarcoma provides selection advantages but allows immunotherapeutic targeting.

Authors:  Kang Yi Lee; Hiu Yi Wong; Qun Zeng; Jia Le Lin; Man Si Cheng; Chik Hong Kuick; Kenneth Tou En Chang; Amos Hong Pheng Loh; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2021-02-04       Impact factor: 8.110

4.  Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions.

Authors:  Qiuxian Zheng; Qin Yang; Jiaming Zhou; Xinyu Gu; Haibo Zhou; Xuejun Dong; Haihong Zhu; Zhi Chen
Journal:  Cancer Cell Int       Date:  2021-06-30       Impact factor: 5.722

5.  Precise mapping of the CD95 pre-ligand assembly domain.

Authors:  Valérie Edmond; Benoist Ghali; Aubin Penna; Jean-Luc Taupin; Sophie Daburon; Jean-François Moreau; Patrick Legembre
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

6.  Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy.

Authors:  Hui Xiao; Hemant Kumar Bid; Xiang Chen; Xiaojuan Wu; Jia Wei; Yang Bian; Chengguang Zhao; Huameng Li; Chenglong Li; Jiayuh Lin
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.